APOBEC3C and prostate carcinoma: Some investigations have shown that the expression of APOBEC3C played a positive role in the invasiveness and prognosis of breast cancer (Zhang et al., 2015; Wang et al., 2019), hepatocellular carcinoma (Yang et al., 2015), and prostate cancer (Kawahara et al., 2019).